Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients (EPIPHARM)

University Hospital, Lille

Status: Terminated

Conditions: Epilepsy

Treatments: Other: Pharmacist intervention; Other: Standard of care

Study type: Interventional

Funder types: Other

Identifiers

NCT04876820

2020_84

2021-A00578-33 (Other Identifier)

Details and patient eligibility

About

Many studies have reported a disparity in medication adherence among epileptic patients. In this population, Medication Possession Ratio (MPR) is an index of medication adherence. MPR is defined as the ratio of the number of days of treatment delivered to the number of days in the period of interest.

No-adherents patients are defined by a MPR of less than 80% , in whom an increase in seizures and the rate of hospitalization can be observed. A pharmacist-led intervention and medication information to epileptic patients could improve patient medication adherence to antiepileptic drugs, and possibly decrease the frequency of seizures, hospitalizations and the health costs generated by these hospitalizations. This intervention could also improve patient knowledge about their medications.

The aim of this study is to evaluate the effectiveness of a pharmacist-led intervention on medication adherence of epileptic patients with the MPR. Secondary objectives include the comparison of medication adherence with health insurance score, the evaluation of patients knowledges about their medications, community pharmacists' satisfaction about community hospital network, the comparison of the seizure free patient rate and the comparison of the rate of patient in whom seizure have decreased by 50%

Enrollment: 51 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Epileptic patients seeing a neurologist in the neurophysiology clinic with a regular follow-up by the Lille University Hospital reference center
• Adult over 18 years old
• Living at home
• Socially insured patient
• In the case of cognitive problems, the presence of a reliable caregiver managing the medications

Exclusion criteria

• Inpatients
• Patient under curatorship, guardianship and/or institutionalized
• Dementia
• Patient who has participated in a therapeutic education program (TEP) about his epilepsy within the previous two years
• Administrative reasons: impossibility to receive informed information, impossibility to participate in the entire study, lack of coverage by the social security system, refusal to sign the consent form.
• Switching to home care by a registered nurse for treatment management

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

51 participants in 2 patient groups

Pharmacist-led intervention

Experimental group

Treatment:

Other: Pharmacist intervention

Standard of care

Sham Comparator group

Treatment:

Other: Standard of care